Janux Therapeutics, Inc. (JANX)
15.59
-0.15
(-0.95%)
USD |
NASDAQ |
Dec 10, 16:00
15.51
-0.08
(-0.51%)
After-Hours: 17:54
Janux Therapeutics Total Assets (Quarterly): 1.025B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Stoke Therapeutics, Inc. | 360.26M |
| Ionis Pharmaceuticals, Inc. | 3.033B |
| Editas Medicine, Inc. | 201.75M |
| Syndax Pharmaceuticals, Inc. | 551.79M |
| Entrada Therapeutics, Inc. | 412.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.21M |
| Shareholders Equity (Quarterly) | 976.56M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 35.86 |
| Net Debt Paydown Yield | 0.02% |